Click for best price
Pharmacogenomics Services Market Size, Share 2023
The global Pharmacogenomics Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Pharmacogenomics Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacogenomics Services. This report contains market size and forecasts of Pharmacogenomics Services in global, including the following market information:
- Global Pharmacogenomics Services Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Genotyping Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmacogenomics Services include Abbott Laboratories, Admera Health, LLC, Mesa Laboratories, Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd., GeneOmbio Technologies Pvt Ltd., Exact Sciences Corporation, Illumina, Inc. and Laboratory Corporation of America Holdings, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Pharmacogenomics Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmacogenomics Services Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Pharmacogenomics Services Market Segment Percentages, by Type, 2022 (%)
- Genotyping
- SNP Identification
- Pharmacogenetic Testing
- Others
Global Pharmacogenomics Services Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Pharmacogenomics Services Market Segment Percentages, by Application, 2022 (%)
- Oncology
- Infectious Diseases
- Psychiatry
- Cardiovascular
- Others
Global Pharmacogenomics Services Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Pharmacogenomics Services Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Pharmacogenomics Services revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Pharmacogenomics Services revenues share in global market, 2022 (%)
key players include:
- Abbott Laboratories
- Admera Health, LLC
- Mesa Laboratories, Inc.
- Dynamic DNA Laboratories
- F. Hoffmann-La Roche Ltd.
- GeneOmbio Technologies Pvt Ltd.
- Exact Sciences Corporation
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Myriad Genetics, Inc.
- OmeCare
- QIAGEN N.V.
- Quest Diagnostics Incorporated
- Thermo Fisher Scientific Inc.
- Precipio
- 23andMe, Inc.
- OneOme, LLC
- DiaCarta, Inc.
- OPKO Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmacogenomics Services, market overview.
Chapter 2: Global Pharmacogenomics Services market size in revenue.
Chapter 3: Detailed analysis of Pharmacogenomics Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmacogenomics Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pharmacogenomics Services Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
105 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pharmacogenomics Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmacogenomics Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmacogenomics Services Overall Market Size
2.1 Global Pharmacogenomics Services Market Size: 2022 VS 2032
2.2 Global Pharmacogenomics Services Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmacogenomics Services Players in Global Market
3.2 Top Global Pharmacogenomics Services Companies Ranked by Revenue
3.3 Global Pharmacogenomics Services Revenue by Companies
3.4 Top 3 and Top 5 Pharmacogenomics Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharmacogenomics Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmacogenomics Services Players in Global Market
3.6.1 List of Global Tier 1 Pharmacogenomics Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmacogenomics Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmacogenomics Services Market Size Markets, 2022 & 2032
4.1.2 Genotyping
4.1.3 SNP Identification
4.1.4 Pharmacogenetic Testing
4.1.5 Others
4.2 By Type - Global Pharmacogenomics Services Revenue & Forecasts
4.2.1 By Type - Global Pharmacogenomics Services Revenue, 2018-2023
4.2.2 By Type - Global Pharmacogenomics Services Revenue, 2024-2032
4.2.3 By Type - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmacogenomics Services Market Size, 2022 & 2032
5.1.2 Oncology
5.1.3 Infectious Diseases
5.1.4 Psychiatry
5.1.5 Cardiovascular
5.1.6 Others
5.2 By Application - Global Pharmacogenomics Services Revenue & Forecasts
5.2.1 By Application - Global Pharmacogenomics Services Revenue, 2018-2023
5.2.2 By Application - Global Pharmacogenomics Services Revenue, 2024-2032
5.2.3 By Application - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Pharmacogenomics Services Market Size, 2022 & 2032
6.2 By Region - Global Pharmacogenomics Services Revenue & Forecasts
6.2.1 By Region - Global Pharmacogenomics Services Revenue, 2018-2023
6.2.2 By Region - Global Pharmacogenomics Services Revenue, 2024-2032
6.2.3 By Region - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Pharmacogenomics Services Revenue, 2018-2032
6.3.2 US Pharmacogenomics Services Market Size, 2018-2032
6.3.3 Canada Pharmacogenomics Services Market Size, 2018-2032
6.3.4 Mexico Pharmacogenomics Services Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Pharmacogenomics Services Revenue, 2018-2032
6.4.2 Germany Pharmacogenomics Services Market Size, 2018-2032
6.4.3 France Pharmacogenomics Services Market Size, 2018-2032
6.4.4 U.K. Pharmacogenomics Services Market Size, 2018-2032
6.4.5 Italy Pharmacogenomics Services Market Size, 2018-2032
6.4.6 Russia Pharmacogenomics Services Market Size, 2018-2032
6.4.7 Nordic Countries Pharmacogenomics Services Market Size, 2018-2032
6.4.8 Benelux Pharmacogenomics Services Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Pharmacogenomics Services Revenue, 2018-2032
6.5.2 China Pharmacogenomics Services Market Size, 2018-2032
6.5.3 Japan Pharmacogenomics Services Market Size, 2018-2032
6.5.4 South Korea Pharmacogenomics Services Market Size, 2018-2032
6.5.5 Southeast Asia Pharmacogenomics Services Market Size, 2018-2032
6.5.6 India Pharmacogenomics Services Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Pharmacogenomics Services Revenue, 2018-2032
6.6.2 Brazil Pharmacogenomics Services Market Size, 2018-2032
6.6.3 Argentina Pharmacogenomics Services Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmacogenomics Services Revenue, 2018-2032
6.7.2 Turkey Pharmacogenomics Services Market Size, 2018-2032
6.7.3 Israel Pharmacogenomics Services Market Size, 2018-2032
6.7.4 Saudi Arabia Pharmacogenomics Services Market Size, 2018-2032
6.7.5 UAE Pharmacogenomics Services Market Size, 2018-2032
7 Pharmacogenomics Services Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Pharmacogenomics Services Major Product Offerings
7.1.4 Abbott Laboratories Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Admera Health, LLC
7.2.1 Admera Health, LLC Company Summary
7.2.2 Admera Health, LLC Business Overview
7.2.3 Admera Health, LLC Pharmacogenomics Services Major Product Offerings
7.2.4 Admera Health, LLC Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.2.5 Admera Health, LLC Key News & Latest Developments
7.3 Mesa Laboratories, Inc.
7.3.1 Mesa Laboratories, Inc. Company Summary
7.3.2 Mesa Laboratories, Inc. Business Overview
7.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Major Product Offerings
7.3.4 Mesa Laboratories, Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.3.5 Mesa Laboratories, Inc. Key News & Latest Developments
7.4 Dynamic DNA Laboratories
7.4.1 Dynamic DNA Laboratories Company Summary
7.4.2 Dynamic DNA Laboratories Business Overview
7.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Major Product Offerings
7.4.4 Dynamic DNA Laboratories Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.4.5 Dynamic DNA Laboratories Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 GeneOmbio Technologies Pvt Ltd.
7.6.1 GeneOmbio Technologies Pvt Ltd. Company Summary
7.6.2 GeneOmbio Technologies Pvt Ltd. Business Overview
7.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Major Product Offerings
7.6.4 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.6.5 GeneOmbio Technologies Pvt Ltd. Key News & Latest Developments
7.7 Exact Sciences Corporation
7.7.1 Exact Sciences Corporation Company Summary
7.7.2 Exact Sciences Corporation Business Overview
7.7.3 Exact Sciences Corporation Pharmacogenomics Services Major Product Offerings
7.7.4 Exact Sciences Corporation Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.7.5 Exact Sciences Corporation Key News & Latest Developments
7.8 Illumina, Inc.
7.8.1 Illumina, Inc. Company Summary
7.8.2 Illumina, Inc. Business Overview
7.8.3 Illumina, Inc. Pharmacogenomics Services Major Product Offerings
7.8.4 Illumina, Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.8.5 Illumina, Inc. Key News & Latest Developments
7.9 Laboratory Corporation of America Holdings
7.9.1 Laboratory Corporation of America Holdings Company Summary
7.9.2 Laboratory Corporation of America Holdings Business Overview
7.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Major Product Offerings
7.9.4 Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.9.5 Laboratory Corporation of America Holdings Key News & Latest Developments
7.10 Myriad Genetics, Inc.
7.10.1 Myriad Genetics, Inc. Company Summary
7.10.2 Myriad Genetics, Inc. Business Overview
7.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Major Product Offerings
7.10.4 Myriad Genetics, Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.10.5 Myriad Genetics, Inc. Key News & Latest Developments
7.11 OmeCare
7.11.1 OmeCare Company Summary
7.11.2 OmeCare Business Overview
7.11.3 OmeCare Pharmacogenomics Services Major Product Offerings
7.11.4 OmeCare Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.11.5 OmeCare Key News & Latest Developments
7.12 QIAGEN N.V.
7.12.1 QIAGEN N.V. Company Summary
7.12.2 QIAGEN N.V. Business Overview
7.12.3 QIAGEN N.V. Pharmacogenomics Services Major Product Offerings
7.12.4 QIAGEN N.V. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.12.5 QIAGEN N.V. Key News & Latest Developments
7.13 Quest Diagnostics Incorporated
7.13.1 Quest Diagnostics Incorporated Company Summary
7.13.2 Quest Diagnostics Incorporated Business Overview
7.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Major Product Offerings
7.13.4 Quest Diagnostics Incorporated Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.13.5 Quest Diagnostics Incorporated Key News & Latest Developments
7.14 Thermo Fisher Scientific Inc.
7.14.1 Thermo Fisher Scientific Inc. Company Summary
7.14.2 Thermo Fisher Scientific Inc. Business Overview
7.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Major Product Offerings
7.14.4 Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.14.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.15 Precipio
7.15.1 Precipio Company Summary
7.15.2 Precipio Business Overview
7.15.3 Precipio Pharmacogenomics Services Major Product Offerings
7.15.4 Precipio Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.15.5 Precipio Key News & Latest Developments
7.16 23andMe, Inc.
7.16.1 23andMe, Inc. Company Summary
7.16.2 23andMe, Inc. Business Overview
7.16.3 23andMe, Inc. Pharmacogenomics Services Major Product Offerings
7.16.4 23andMe, Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.16.5 23andMe, Inc. Key News & Latest Developments
7.17 OneOme, LLC
7.17.1 OneOme, LLC Company Summary
7.17.2 OneOme, LLC Business Overview
7.17.3 OneOme, LLC Pharmacogenomics Services Major Product Offerings
7.17.4 OneOme, LLC Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.17.5 OneOme, LLC Key News & Latest Developments
7.18 DiaCarta, Inc.
7.18.1 DiaCarta, Inc. Company Summary
7.18.2 DiaCarta, Inc. Business Overview
7.18.3 DiaCarta, Inc. Pharmacogenomics Services Major Product Offerings
7.18.4 DiaCarta, Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.18.5 DiaCarta, Inc. Key News & Latest Developments
7.19 OPKO Health
7.19.1 OPKO Health Company Summary
7.19.2 OPKO Health Business Overview
7.19.3 OPKO Health Pharmacogenomics Services Major Product Offerings
7.19.4 OPKO Health Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.19.5 OPKO Health Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pharmacogenomics Services Market Opportunities & Trends in Global Market
Table 2. Pharmacogenomics Services Market Drivers in Global Market
Table 3. Pharmacogenomics Services Market Restraints in Global Market
Table 4. Key Players of Pharmacogenomics Services in Global Market
Table 5. Top Pharmacogenomics Services Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pharmacogenomics Services Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pharmacogenomics Services Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pharmacogenomics Services Product Type
Table 9. List of Global Tier 1 Pharmacogenomics Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmacogenomics Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pharmacogenomics Services Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Pharmacogenomics Services Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pharmacogenomics Services Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Pharmacogenomics Services Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Pharmacogenomics Services Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pharmacogenomics Services Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Pharmacogenomics Services Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Pharmacogenomics Services Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pharmacogenomics Services Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Pharmacogenomics Services Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pharmacogenomics Services Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Pharmacogenomics Services Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pharmacogenomics Services Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Pharmacogenomics Services Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pharmacogenomics Services Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Pharmacogenomics Services Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pharmacogenomics Services Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Pharmacogenomics Services Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pharmacogenomics Services Revenue, (US$, Mn), 2024-2032
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Pharmacogenomics Services Product Offerings
Table 32. Abbott Laboratories Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Admera Health, LLC Company Summary
Table 35. Admera Health, LLC Pharmacogenomics Services Product Offerings
Table 36. Admera Health, LLC Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 37. Admera Health, LLC Key News & Latest Developments
Table 38. Mesa Laboratories, Inc. Company Summary
Table 39. Mesa Laboratories, Inc. Pharmacogenomics Services Product Offerings
Table 40. Mesa Laboratories, Inc. Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 41. Mesa Laboratories, Inc. Key News & Latest Developments
Table 42. Dynamic DNA Laboratories Company Summary
Table 43. Dynamic DNA Laboratories Pharmacogenomics Services Product Offerings
Table 44. Dynamic DNA Laboratories Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 45. Dynamic DNA Laboratories Key News & Latest Developments
Table 46. F. Hoffmann-La Roche Ltd. Company Summary
Table 47. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Offerings
Table 48. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 49. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 50. GeneOmbio Technologies Pvt Ltd. Company Summary
Table 51. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Offerings
Table 52. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 53. GeneOmbio Technologies Pvt Ltd. Key News & Latest Developments
Table 54. Exact Sciences Corporation Company Summary
Table 55. Exact Sciences Corporation Pharmacogenomics Services Product Offerings
Table 56. Exact Sciences Corporation Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 57. Exact Sciences Corporation Key News & Latest Developments
Table 58. Illumina, Inc. Company Summary
Table 59. Illumina, Inc. Pharmacogenomics Services Product Offerings
Table 60. Illumina, Inc. Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 61. Illumina, Inc. Key News & Latest Developments
Table 62. Laboratory Corporation of America Holdings Company Summary
Table 63. Laboratory Corporation of America Holdings Pharmacogenomics Services Product Offerings
Table 64. Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 65. Laboratory Corporation of America Holdings Key News & Latest Developments
Table 66. Myriad Genetics, Inc. Company Summary
Table 67. Myriad Genetics, Inc. Pharmacogenomics Services Product Offerings
Table 68. Myriad Genetics, Inc. Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 69. Myriad Genetics, Inc. Key News & Latest Developments
Table 70. OmeCare Company Summary
Table 71. OmeCare Pharmacogenomics Services Product Offerings
Table 72. OmeCare Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 73. OmeCare Key News & Latest Developments
Table 74. QIAGEN N.V. Company Summary
Table 75. QIAGEN N.V. Pharmacogenomics Services Product Offerings
Table 76. QIAGEN N.V. Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 77. QIAGEN N.V. Key News & Latest Developments
Table 78. Quest Diagnostics Incorporated Company Summary
Table 79. Quest Diagnostics Incorporated Pharmacogenomics Services Product Offerings
Table 80. Quest Diagnostics Incorporated Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 81. Quest Diagnostics Incorporated Key News & Latest Developments
Table 82. Thermo Fisher Scientific Inc. Company Summary
Table 83. Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Offerings
Table 84. Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 85. Thermo Fisher Scientific Inc. Key News & Latest Developments
Table 86. Precipio Company Summary
Table 87. Precipio Pharmacogenomics Services Product Offerings
Table 88. Precipio Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 89. Precipio Key News & Latest Developments
Table 90. 23andMe, Inc. Company Summary
Table 91. 23andMe, Inc. Pharmacogenomics Services Product Offerings
Table 92. 23andMe, Inc. Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 93. 23andMe, Inc. Key News & Latest Developments
Table 94. OneOme, LLC Company Summary
Table 95. OneOme, LLC Pharmacogenomics Services Product Offerings
Table 96. OneOme, LLC Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 97. OneOme, LLC Key News & Latest Developments
Table 98. DiaCarta, Inc. Company Summary
Table 99. DiaCarta, Inc. Pharmacogenomics Services Product Offerings
Table 100. DiaCarta, Inc. Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 101. DiaCarta, Inc. Key News & Latest Developments
Table 102. OPKO Health Company Summary
Table 103. OPKO Health Pharmacogenomics Services Product Offerings
Table 104. OPKO Health Pharmacogenomics Services Revenue (US$, Mn) & (2018-2023)
Table 105. OPKO Health Key News & Latest Developments
List of Figures
Figure 1. Pharmacogenomics Services Segment by Type in 2022
Figure 2. Pharmacogenomics Services Segment by Application in 2022
Figure 3. Global Pharmacogenomics Services Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pharmacogenomics Services Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Pharmacogenomics Services Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmacogenomics Services Revenue in 2022
Figure 8. By Type - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
Figure 9. By Application - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
Figure 10. By Type - Global Pharmacogenomics Services Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
Figure 12. By Application - Global Pharmacogenomics Services Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
Figure 14. By Region - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
Figure 15. By Country - North America Pharmacogenomics Services Revenue Market Share, 2018-2032
Figure 16. US Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Pharmacogenomics Services Revenue Market Share, 2018-2032
Figure 20. Germany Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 21. France Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Pharmacogenomics Services Revenue Market Share, 2018-2032
Figure 28. China Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 32. India Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Pharmacogenomics Services Revenue Market Share, 2018-2032
Figure 34. Brazil Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Pharmacogenomics Services Revenue Market Share, 2018-2032
Figure 37. Turkey Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Pharmacogenomics Services Revenue, (US$, Mn), 2018-2032
Figure 41. Abbott Laboratories Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Admera Health, LLC Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mesa Laboratories, Inc. Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Dynamic DNA Laboratories Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Exact Sciences Corporation Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Illumina, Inc. Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Myriad Genetics, Inc. Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. OmeCare Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. QIAGEN N.V. Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Quest Diagnostics Incorporated Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Precipio Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. 23andMe, Inc. Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. OneOme, LLC Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. DiaCarta, Inc. Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. OPKO Health Pharmacogenomics Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
